Cancer's hidden toll: study probes social struggles of young patients
NCT ID NCT04328350
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how cancer treatment changes the social lives of adolescents and young adults aged 15 to 22. Researchers will survey patients on and off therapy about their friendships, loneliness, and family relationships. The goal is to understand their social needs and guide future support programs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward better psychosocial support programs to help young cancer patients maintain friendships and social well-being.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve health, and findings may not apply to all young cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
121 people
The number who actually took part.
- Started
-
Oct 2020
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All participants who meet eligibility criteria and consent to enrollment on the study.
- Ages
-
15 to 22 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All Participants * Age 15 - 22 * Primary oncology diagnosis. * Reads and speaks English. * On-Therapy Strata * 2 - 12 months from diagnosis and receiving cancer-directed therapy. * Off-Therapy Strata * 1 - 4 years post-treatment, diagnosed at ≥13 years of age. * Caregivers Reads and speaks English * Consent received from adult participant to contact, as it applies Exclusion Criteria: * Surgery only treatment plan. * IQ less than 70 as documented in the medical record. * Diagnosis of a genetic disorder/pre-existing neurodevelopmental condition associated with neurocognitive or social impairment (e.g., autism, Neurofibromatosis Type 1 (NF1), Down syndrome). * Inability or unwillingness of research participant or legal - guardian/representative to give written informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- The forgotten siblings: can two surveys give voice to children living beside a brother or sister with cancer?
- Can a gentler blood thinner shield cancer patients from new clots?
- Can more phone calls after cancer surgery keep patients out of the hospital?
- Live music meets virtual reality: can a Three-Session program reach advanced cancer patients in palliative care?
- Matching cancer survivors to the right level of support